MAPKAPK2 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma, inhibition of MAPKAPK2 reduced the production of inflammatory cytokines including IL-1α, IL-1β, and IL-6 induced by radiotherapy (6).